The use of mechanical circulatory support using percutaneous ventricular assist devices (pVAD)
has increased rapidly during the last decade without substantial new evidence for their …

… Norepinephrine is the preferred agent for patients in cardiogenic shock who require pressor
support; … Table 3Modes of mechanical support in cardiogenic shock (mechanism of action) …

Extracorporeal membrane oxygenation (ECMO) is an increasingly used supportive measure
for patients with refractory cardiogenic shock (CS). Despite its increasing use, there remain …

… oxygenator (ECMO or extracorporeal life support, ECLS) are recommended in CS refractory
to other treatments. Mechanical circulatory support devices serve as bridge therapies to …

… of shock is rapid and fatal. In Part 1 of this Review, we examine the evolving clinical profile of
cardiogenic shock, … condition since the results of the SHOCK trial 4 were published in 1999. …

… Single-center study of consecutive patients with cardiogenic shock due to AMI (n = 26)
and ESHF (n = 42) who underwent MCS (extracorporeal life support, Impella or temporary …

… We aimed to identify prognostic laboratory markers during extracorporeal life support (ECLS)
in patients with primary refractory cardiogenic shock (RCS) and to create a preliminary …

… of using extracorporeal life support (ECLS) to … cardiogenic shock. Intra-aortic balloon pump
and ECLS were deployed within 45 minutes after the insult to restore the circulatory support …

… Percutaneous ventricular assist devices are a promising therapy for temporary support of
patients in cardiogenic shock, but rigorous clinical data demonstrating improved outcomes are …

… For us, the results of this meta-analysis with respect to refractory cardiac arrest are more
convincing than those for cardiogenic shock. They further support the resuscitation guidelines (8,…